| UniProt ID | GDIR2_HUMAN | |
|---|---|---|
| UniProt AC | P52566 | |
| Protein Name | Rho GDP-dissociation inhibitor 2 | |
| Gene Name | ARHGDIB | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 201 | |
| Subcellular Localization | Cytoplasm, cytosol . | |
| Protein Description | Regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. [PubMed: 8356058] | |
| Protein Sequence | MTEKAPEPHVEEDDDDELDSKLNYKPPPQKSLKELQEMDKDDESLIKYKKTLLGDGPVVTDPKAPNVVVTRLTLVCESAPGPITMDLTGDLEALKKETIVLKEGSEYRVKIHFKVNRDIVSGLKYVQHTYRTGVKVDKATFMVGSYGPRPEEYEFLTPVEEAPKGMLARGTYHNKSFFTDDDKQDHLSWEWNLSIKKEWTE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MTEKAPEPH ------CCCCCCCCC | 46.31 | - | |
| 2 | Phosphorylation | ------MTEKAPEPH ------CCCCCCCCC | 46.31 | 26074081 | |
| 4 | Acetylation | ----MTEKAPEPHVE ----CCCCCCCCCCC | 61.14 | 25953088 | |
| 4 | Ubiquitination | ----MTEKAPEPHVE ----CCCCCCCCCCC | 61.14 | - | |
| 20 | Phosphorylation | DDDDELDSKLNYKPP CCCCCCHHHCCCCCC | 52.22 | 28787133 | |
| 21 | Acetylation | DDDELDSKLNYKPPP CCCCCHHHCCCCCCC | 40.18 | 19608861 | |
| 21 | Ubiquitination | DDDELDSKLNYKPPP CCCCCHHHCCCCCCC | 40.18 | 19608861 | |
| 24 | Nitration | ELDSKLNYKPPPQKS CCHHHCCCCCCCCHH | 35.00 | - | |
| 24 | Phosphorylation | ELDSKLNYKPPPQKS CCHHHCCCCCCCCHH | 35.00 | 19321744 | |
| 25 | Acetylation | LDSKLNYKPPPQKSL CHHHCCCCCCCCHHH | 50.39 | 19608861 | |
| 25 | Ubiquitination | LDSKLNYKPPPQKSL CHHHCCCCCCCCHHH | 50.39 | 19608861 | |
| 30 | Acetylation | NYKPPPQKSLKELQE CCCCCCCHHHHHHHH | 64.63 | 23749302 | |
| 30 | Ubiquitination | NYKPPPQKSLKELQE CCCCCCCHHHHHHHH | 64.63 | 19608861 | |
| 31 | Phosphorylation | YKPPPQKSLKELQEM CCCCCCHHHHHHHHC | 39.15 | 29978859 | |
| 33 | Ubiquitination | PPPQKSLKELQEMDK CCCCHHHHHHHHCCC | 64.57 | - | |
| 33 | Acetylation | PPPQKSLKELQEMDK CCCCHHHHHHHHCCC | 64.57 | 23749302 | |
| 38 | Sulfoxidation | SLKELQEMDKDDESL HHHHHHHCCCCCHHH | 5.11 | 28465586 | |
| 40 | Ubiquitination | KELQEMDKDDESLIK HHHHHCCCCCHHHHH | 66.81 | 19608861 | |
| 40 | Acetylation | KELQEMDKDDESLIK HHHHHCCCCCHHHHH | 66.81 | 19608861 | |
| 44 | Phosphorylation | EMDKDDESLIKYKKT HCCCCCHHHHHHHHH | 42.25 | 28348404 | |
| 47 | Ubiquitination | KDDESLIKYKKTLLG CCCHHHHHHHHHHHC | 57.20 | 19608861 | |
| 47 | Acetylation | KDDESLIKYKKTLLG CCCHHHHHHHHHHHC | 57.20 | 19608861 | |
| 48 | Phosphorylation | DDESLIKYKKTLLGD CCHHHHHHHHHHHCC | 15.66 | 29978859 | |
| 49 | Ubiquitination | DESLIKYKKTLLGDG CHHHHHHHHHHHCCC | 33.99 | - | |
| 50 | Ubiquitination | ESLIKYKKTLLGDGP HHHHHHHHHHHCCCC | 41.12 | 21890473 | |
| 50 | Ubiquitination | ESLIKYKKTLLGDGP HHHHHHHHHHHCCCC | 41.12 | 21890473 | |
| 51 | Phosphorylation | SLIKYKKTLLGDGPV HHHHHHHHHHCCCCC | 24.06 | 23911959 | |
| 60 | Phosphorylation | LGDGPVVTDPKAPNV HCCCCCCCCCCCCCE | 46.98 | 23911959 | |
| 63 | Acetylation | GPVVTDPKAPNVVVT CCCCCCCCCCCEEEE | 78.33 | 23749302 | |
| 63 | Ubiquitination | GPVVTDPKAPNVVVT CCCCCCCCCCCEEEE | 78.33 | - | |
| 70 | O-linked_Glycosylation | KAPNVVVTRLTLVCE CCCCEEEEEEEEEEE | 14.35 | 30379171 | |
| 73 | Phosphorylation | NVVVTRLTLVCESAP CEEEEEEEEEEECCC | 17.54 | 28122231 | |
| 73 | O-linked_Glycosylation | NVVVTRLTLVCESAP CEEEEEEEEEEECCC | 17.54 | 30379171 | |
| 76 | S-nitrosylation | VTRLTLVCESAPGPI EEEEEEEEECCCCCE | 3.73 | 25040305 | |
| 78 | Phosphorylation | RLTLVCESAPGPITM EEEEEEECCCCCEEE | 34.34 | 28122231 | |
| 95 | Ubiquitination | TGDLEALKKETIVLK CCCHHHHHHCEEEEE | 56.46 | - | |
| 95 | Acetylation | TGDLEALKKETIVLK CCCHHHHHHCEEEEE | 56.46 | 26822725 | |
| 96 | Ubiquitination | GDLEALKKETIVLKE CCHHHHHHCEEEEEC | 62.02 | - | |
| 102 | Ubiquitination | KKETIVLKEGSEYRV HHCEEEEECCCEEEE | 49.49 | 19608861 | |
| 102 | Acetylation | KKETIVLKEGSEYRV HHCEEEEECCCEEEE | 49.49 | 19608861 | |
| 110 | Ubiquitination | EGSEYRVKIHFKVNR CCCEEEEEEEEEECC | 22.82 | - | |
| 114 | Ubiquitination | YRVKIHFKVNRDIVS EEEEEEEEECCHHHH | 25.16 | - | |
| 114 | Acetylation | YRVKIHFKVNRDIVS EEEEEEEEECCHHHH | 25.16 | 25953088 | |
| 124 | Ubiquitination | RDIVSGLKYVQHTYR CHHHHHCEEEEEECC | 47.07 | 21890473 | |
| 124 | Ubiquitination | RDIVSGLKYVQHTYR CHHHHHCEEEEEECC | 47.07 | 21906983 | |
| 124 | Acetylation | RDIVSGLKYVQHTYR CHHHHHCEEEEEECC | 47.07 | 19608861 | |
| 125 | Phosphorylation | DIVSGLKYVQHTYRT HHHHHCEEEEEECCC | 15.47 | 23882029 | |
| 129 | Phosphorylation | GLKYVQHTYRTGVKV HCEEEEEECCCCCEE | 9.52 | 28176486 | |
| 130 | Phosphorylation | LKYVQHTYRTGVKVD CEEEEEECCCCCEEC | 12.21 | 28176486 | |
| 132 | Phosphorylation | YVQHTYRTGVKVDKA EEEEECCCCCEECEE | 35.59 | 27080861 | |
| 135 | Acetylation | HTYRTGVKVDKATFM EECCCCCEECEEEEE | 46.17 | 23749302 | |
| 135 | Ubiquitination | HTYRTGVKVDKATFM EECCCCCEECEEEEE | 46.17 | - | |
| 138 | Acetylation | RTGVKVDKATFMVGS CCCCEECEEEEEEEC | 52.92 | 23749302 | |
| 138 | Ubiquitination | RTGVKVDKATFMVGS CCCCEECEEEEEEEC | 52.92 | - | |
| 140 | Phosphorylation | GVKVDKATFMVGSYG CCEECEEEEEEECCC | 20.29 | 28464451 | |
| 145 | Phosphorylation | KATFMVGSYGPRPEE EEEEEEECCCCCHHH | 18.59 | 22617229 | |
| 146 | Phosphorylation | ATFMVGSYGPRPEEY EEEEEECCCCCHHHC | 25.81 | 22115753 | |
| 153 | Phosphorylation | YGPRPEEYEFLTPVE CCCCHHHCEEEEEHH | 15.43 | 19321744 | |
| 157 | Phosphorylation | PEEYEFLTPVEEAPK HHHCEEEEEHHHCCC | 30.52 | 30108239 | |
| 164 | Ubiquitination | TPVEEAPKGMLARGT EEHHHCCCCCCCCCC | 65.09 | 21890473 | |
| 175 | Ubiquitination | ARGTYHNKSFFTDDD CCCCCCCCCCCCCCC | 35.01 | 19608861 | |
| 175 | Acetylation | ARGTYHNKSFFTDDD CCCCCCCCCCCCCCC | 35.01 | 19608861 | |
| 179 | Phosphorylation | YHNKSFFTDDDKQDH CCCCCCCCCCCCCCC | 36.19 | - | |
| 194 | Phosphorylation | LSWEWNLSIKKEWTE CEEEEEEEEEECCCC | 29.20 | 27251275 | |
| 196 | Acetylation | WEWNLSIKKEWTE-- EEEEEEEEECCCC-- | 41.06 | 25953088 | |
| 197 | Acetylation | EWNLSIKKEWTE--- EEEEEEEECCCC--- | 57.73 | 11921139 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 24 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
| 24 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 31 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
| 130 | Y | Phosphorylation | Kinase | ABL | P00519 | PSP |
| 153 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | RNF128 | Q8TEB7 | PMID:17114425 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GDIR2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GDIR2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| VAV_HUMAN | VAV1 | physical | 10664460 | |
| A4_HUMAN | APP | physical | 21832049 | |
| RHOC_HUMAN | RHOC | physical | 26344197 | |
| SUMO4_HUMAN | SUMO4 | physical | 26344197 | |
| WSB1_HUMAN | WSB1 | physical | 26424695 | |
| FBXL5_HUMAN | FBXL5 | physical | 27383304 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-21; LYS-25; LYS-40; LYS-47;LYS-102; LYS-124 AND LYS-175, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-145, AND MASSSPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-24, AND MASSSPECTROMETRY. | |